Mark H. Kirschbaum
Mark H. Kirschbaum publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Histone Deacetylase Inhibitors Research, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #1,020,242 of 7,710,434 ranked researchers
- Rank in United States
- #332,403 of 1,627,098
- Works
- 148
- Citations
- 8.6k
- Citations per work
- 58.4
What does Mark H. Kirschbaum research?
Mark H. Kirschbaum's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8456.8%
- Medicine8456.8%
- Life Sciences4127.9%
- Everything else2315.3%
- 1Molecular Biology24% of their works
- 2Hematology23% of their works
- 3Oncology15% of their works
- 4Pathology and Forensic Medicine12% of their works
- 5Genetics8% of their works
- 6Immunology4% of their works
Research topics
Which keywords describe Mark H. Kirschbaum's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Hematopoietic Stem Cells, HDAC Inhibitors, Histone Deacetylases, Acute Myeloid Leukemia, AML and Classification.
- Acute Lymphoblastic Leukemia
- BCR-ABL
- BET Bromodomains
- Bone Marrow Niche
- Chronic Lymphocytic Leukemia
- Classification
- AML
- HDAC Inhibitors
- Rituximab
- Prognostic Factors
- Hematopoietic Stem Cells
- Histone Deacetylases
- Acute Myeloid Leukemia
- Lymphoma
- Genomic Aberrations
- Graft-versus-Host Disease
- PROTACs
- Imatinib
- Childhood Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors673 topics
- Rituximab542 topics
- Hematopoietic Stem Cells522 topics
- HDAC Inhibitors371 topic
- Histone Deacetylases371 topic
- AML351 topic
- Acute Myeloid Leukemia351 topic
- Classification331 topic
- Lymphoma331 topic
- Chronic Lymphocytic Leukemia211 topic
- Genomic Aberrations211 topic
- Bone Marrow Niche171 topic
- Graft-versus-Host Disease171 topic
- BET Bromodomains161 topic
- PROTACs161 topic
- BCR-ABL131 topic
- Imatinib131 topic
- Acute Lymphoblastic Leukemia111 topic
- Childhood Cancer111 topic
Where does Mark H. Kirschbaum work?
Mark H. Kirschbaum's main affiliation in the publication record is City Of Hope National Medical Center, United States.
How many publications and citations does Mark H. Kirschbaum have?
OpenAlex counts 148 works and 8,649 citations for Mark H. Kirschbaum, an h-index of 30, ranking #1,020,242 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark H. Kirschbaum. Posts are plain text and can be reported.